Syndax Pharmaceuticals Inc.

09/27/2021 | Press release | Distributed by Public on 09/27/2021 04:06

Syndax Pharmaceuticals and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases